(844) 424-4537
EN (Settings)
Login
Get Care
For Patients
For Providers
Research & Innovation
Learn
Give
I Want To
Make an impact today! Donate now
AEWS1221, Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
See protocol/CiRB application
See protocol
Participate